2023 Warrants
Exercisability. The 2023 Warrants are currently exercisable and may be exercised at any time on or before 5:00 PM (Arizona time), on February 15, 2030, at the option of each holder, in whole or in part by surrender of the 2023 Warrant and delivering to the Company a duly executed exercise form accompanied by payment in full for the number of Common Shares purchased upon such exercise (except in the case of a cashless exercise as discussed below).
Cashless Exercise. At any time during the term of the 2023 Warrants, the holder is permitted to effect a cashless exercise of the 2023 Warrants (in whole or in part) by surrender of the 2023 Warrant and delivering to the Company a duly executed exercise form. In the event of such cashless exercise, each holder would pay the exercise price by surrendering the 2023 Warrants for that number of Common Shares equal to the quotient obtained by dividing (x) the number of Common Shares issuable upon exercise of the 2023 Warrant in accordance with its terms by means of a cash exercise rather than a cashless exercise, multiplied by the difference between the exercise price of the 2023 Warrants and the Fair Market Value (as such term is defined in the 2023 Warrants) by (y) the Fair Market Value.
Exercise Price. Each 2023 Warrant represents the right to purchase one Common Share at an exercise price of USD$0.07084 per share, subject to adjustment. The exercise price and/or the shares underlying the 2023 Warrants are subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock consolidations, rights offerings, or capital reorganizations.
Anti-takeover Provisions
The BCBCA, the Articles and Canadian take-over bid rules could discourage or make more difficult a change in control of the Company.
Actions Requiring Special Majority under BCBCA and the Articles
Under the BCBCA and the Articles, certain corporate actions require the approval of a special majority of shareholders, meaning holders of shares representing 66 2/3% of those votes cast in respect of a shareholder vote addressing such matter. Those items requiring the approval of a special majority generally relate to fundamental changes with respect to the Company’s business, and include amongst others, resolutions: (i) removing a director prior to the expiry of his or her term; (ii) altering the Company’s Articles; (iii) approving an amalgamation; (iv) approving a plan of arrangement; and (v) providing for a sale of all or substantially all of the Company’s assets.
Under the Articles, in addition to any other rights provided by law, the Company shall not amend, alter or repeal the preferences, special rights or other powers of the Common Shares or any other provision of the Company’s Notice and Articles that would adversely affect the rights of the holders of Common Share, without the unanimous written consent or affirmative vote of the holders of at least 66 2/3% of the then outstanding aggregate number of Common Shares, given in writing by all of the holders of Common Shares or by vote at a meeting, consenting or voting (as the case may be) separately as a class of the holders of Common Shares.
Additionally, under the Articles, in addition to any other rights provided by law, the Company shall not amend, alter or repeal the preferences, special rights or other powers of the Compressed Shares or any other provision of the Company’s Notice and Articles that would adversely affect the rights of the Compressed Shareholders, without the unanimous written consent or affirmative vote of the holders of at least 66 2/3% of the then outstanding aggregate number of Compressed Shares, given in writing by all of the holders of Compressed Shares or by vote at a meeting, consenting or voting (as the case may be) separately as a class of the holders of Compressed Shares.
Notice Provisions Relating to Nomination of Directors
Under the Articles, a shareholder (a “Nominating Shareholder”) may nominate persons for election to the Board at any annual meeting of shareholders if such shareholder provides notice (“Nominating Notice”) to the Company’s secretary not less than 30 days prior to the date of the annual meeting of shareholders; provided, however, that in the event that the annual meeting of shareholders is to be held on a date that is less than 50 days after the date (the “Notice Date”) on which the first public announcement of the date of the annual meeting is made, the Nominating Notice is made not later